Medidata, a Dassault Systèmes brand, extends collaboration with Sanofi in clinical research to boost innovation, speed new therapies to market, and improve health outcomes globally. The Medidata Experiences offer AI-embedded, platform-based solutions to unify trial processes, reduce costs, and diminish silos in the life sciences industry. Sanofi will utilize Medidata’s expertise in decentralized clinical trials, with end-to-end operational support provided. Lisa Moneymaker, chief strategy officer at Medidata, highlights the importance of simplifying execution and accelerating the clinical development process for biopharma companies like Sanofi through this collaboration.

Read more at GlobeNewswire: Medidata Extends Collaboration with Sanofi for the